{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T10:08:03Z","timestamp":1706522883466},"reference-count":22,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.psychres.2005.05.004","type":"journal-article","created":{"date-parts":[[2005,8,30]],"date-time":"2005-08-30T11:21:25Z","timestamp":1125400885000},"page":"247-250","source":"Crossref","is-referenced-by-count":1,"title":["Platelet vesicular monoamine transporter density in untreated patients diagnosed with social phobia"],"prefix":"10.1016","volume":"136","author":[{"given":"Neil","family":"Laufer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Zucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haggai","family":"Hermesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofi","family":"Marom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Royi","family":"Gilad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vered","family":"Nir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Rehavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2005.05.004_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0924-977X(02)00043-3","article-title":"A preliminary study of buspirone stimulated prolactin release in generalised social phobia: evidence for enhanced serotonergic responsivity?","volume":"12","author":"Condren","year":"2002","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2005.05.004_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1034\/j.1600-0447.108.s417.7.x","article-title":"Pharmacotherapy of social phobia","volume":"417","author":"Davidson","year":"2003","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"key":"10.1016\/j.psychres.2005.05.004_bib3","series-title":"Structured Clinical Interview for DMS-IV Axis I Disorders (SCID), Clinical Version: User's Guide","author":"First","year":"1996"},{"key":"10.1016\/j.psychres.2005.05.004_bib4","series-title":"ECDEU Assessment Manual for Psychopharmacology","article-title":"Clinical Global Impression Severity Scale","author":"Guy","year":"1976"},{"key":"10.1016\/j.psychres.2005.05.004_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-1781(98)00041-9","article-title":"Serotonergic function in social phobia: comparison to normal control and obsessive\u2013compulsive disorder subjects","volume":"79","author":"Hollander","year":"1998","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2005.05.004_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0006-3223(94)91217-3","article-title":"Plasma and CSF HVA levels in panic patients with comorbid social phobia","volume":"36","author":"Johnson","year":"1994","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2005.05.004_bib7","series-title":"Mini International Neuropsychiatric Interview, Version 4.4","author":"Lecrubier","year":"1996"},{"key":"10.1016\/j.psychres.2005.05.004_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/da.10064","article-title":"Psychometric properties and three proposed subscales of a self-report version of the Liebowitz Social Anxiety Scale translated into Hebrew","volume":"16","author":"Levin","year":"2002","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.psychres.2005.05.004_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-1781(87)90054-0","article-title":"MAOI's: impact on social behavior","volume":"22","author":"Liebowitz","year":"1987","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2005.05.004_bib10","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1176\/ajp.138.12.1572","article-title":"School avoidance and social phobia triggered by haloperidol in patients with Tourette's disorder","volume":"138","author":"Mikkelsen","year":"1981","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2005.05.004_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2005.05.004_bib12","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/archpsyc.1981.01780370017001","article-title":"Depressed patients have decreased binding of tritiated imipramine to platelet serotonin \u2018transporter\u2019","volume":"38","author":"Paul","year":"1981","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.psychres.2005.05.004_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1176\/appi.ajp.157.3.457","article-title":"Low dopamine D2 receptor binding potential in social phobia","volume":"157","author":"Schneier","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2005.05.004_bib14","series-title":"The Anxiety Disease","first-page":"148","author":"Sheehan","year":"1983"},{"key":"10.1016\/j.psychres.2005.05.004_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/09537100020000166","article-title":"Platelet noradrenaline and adrenaline efflux in hypercholestrolaemia: studies in platelet-rich plasma","volume":"11","author":"Smith","year":"2000","journal-title":"Platelets"},{"key":"10.1016\/j.psychres.2005.05.004_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/ajp.147.2.217","article-title":"Anxiety disorders in patients with Parkinson's disease","volume":"147","author":"Stein","year":"1990","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2005.05.004_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0006-3223(94)00149-W","article-title":"[3H]Paroxetine binding to platelets of patients with social phobia: comparison to patients with panic disorder and healthy volunteers","volume":"37","author":"Stein","year":"1995","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2005.05.004_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/anxi.3070010505","article-title":"Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia","volume":"1","author":"Tancer","year":"1994","journal-title":"Anxiety"},{"key":"10.1016\/j.psychres.2005.05.004_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1176\/ajp.154.2.239","article-title":"Dopamine reuptake site densities in patients with social phobia","volume":"154","author":"Tiihonen","year":"1997","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2005.05.004_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1520-6394(2000)11:1<45::AID-DA8>3.0.CO;2-8","article-title":"Treatment of social phobia with the dopamine agonist pergolide","volume":"11","author":"Villarreal","year":"2000","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.psychres.2005.05.004_bib21","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/S0024-3205(01)01301-7","article-title":"Characterization of high-affinity [3H]TBZOH binding to human platelet vesicular monoamine transporter","volume":"69","author":"Zucker","year":"2001","journal-title":"Life Sciences"},{"key":"10.1016\/j.psychres.2005.05.004_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0165-1781(02)00223-8","article-title":"Elevated platelet vesicular monoamine transporter density in untreated patients diagnosed with major depression","volume":"112","author":"Zucker","year":"2002","journal-title":"Psychiatry Research"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178105001393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178105001393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T09:17:29Z","timestamp":1706519849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178105001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":22,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0165178105001393"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2005.05.004","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}